CorMedix CRMD and Theravance Biopharma TBPH occupy a similar niche in the market as small-cap biopharmaceutical companies working to turn promising science into sustainable revenues. Both companies, ...
The S&P/ASX Small Ordinaries Index (XSO) closed at 3,553.80 yesterday, up 0.087% or 3.10 points. The index has gained 4.36% over the past five days, adding 148.50 points as small-cap investor ...
In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...
The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,390.60, down 6.60 points or 0.19% in the latest session. The index has fallen 2.10% over the past five trading days, reflecting ongoing ...
After years of trailing their large-cap peers, small-cap stocks have tested the patience of even seasoned investors. We believe small-cap companies stand to be the biggest beneficiaries of the US ...
Many small-cap funds lagged their benchmarks by wide margins in 2025 while putting up respectable absolute returns. Strategies that eschew speculative small caps and focus on higher-quality companies, ...